• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO CLINICAL DIAGNOSTICS, INC. RED BLOOD CELL DILUENT MTS DILUENT 2; MEDIA, POTENTIATING FOR IN VITRO DIAGNOSTIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO CLINICAL DIAGNOSTICS, INC. RED BLOOD CELL DILUENT MTS DILUENT 2; MEDIA, POTENTIATING FOR IN VITRO DIAGNOSTIC USE Back to Search Results
Lot Number MD142
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem Insufficient Information (4580)
Event Date 09/23/2020
Event Type  malfunction  
Event Description
The bottles of mts diluent 2 and mts diluent 2 plus look nearly identical making it easy to inadvertently select the wrong bottle of diluent.This has potential to cause an important medical event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RED BLOOD CELL DILUENT MTS DILUENT 2
Type of Device
MEDIA, POTENTIATING FOR IN VITRO DIAGNOSTIC USE
Manufacturer (Section D)
ORTHO CLINICAL DIAGNOSTICS, INC.
MDR Report Key10843806
MDR Text Key216632037
Report NumberMW5097895
Device Sequence Number2
Product Code KSG
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 11/12/2020
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received11/13/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date08/03/2021
Device Lot NumberMD142
Is the Reporter a Health Professional? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-